Beam Therapeutics Inc (NASDAQ:BEAM) shares, rose in value on Thursday, April 25, with the stock price down by -5.74% to the previous day’s close as strong demand from buyers drove the stock to $21.43.
Actively observing the price movement in the recent trading, the stock is buoying the session at $22.74. Referring to stock’s 52-week performance, its high was $49.50, and the low was $16.95. On the whole, BEAM has fluctuated by -35.48% over the past month.
Wall Street analysts also predicted that the company’s y-o-y revenues would reach 16.97M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that BEAM’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of BEAM currently trading nearly -22.02% and -33.86% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 20.63, while the 7-day volatility ratio is showing 5.44% which for the 30-day chart, stands at 4.54%. Furthermore, Beam Therapeutics Inc (BEAM)’s beta value is 1.85, and its average true range (ATR) is 1.61.
A comparison of Beam Therapeutics Inc (BEAM) with its peers suggests the former has fared considerably weaker in the market. BEAM showed an intraday change of -5.74% in today’s session so far, and over the past year, it shrunk by -29.58%%.
Data on historical trading for Beam Therapeutics Inc (NASDAQ:BEAM) indicates that the trading volumes over the past 3 months, they’ve averaged 1.52 million. According to company’s latest data on outstanding shares, there are 81.63 million shares outstanding.
Nearly 16.88% of Beam Therapeutics Inc’s shares belong to company insiders and institutional investors own 78.45% of the company’s shares. The stock has fallen by -21.25% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the BEAM stock heading into the next quarter.
